Influence of PPAR-gama receptor agonists on antitumor activity of photodynamic therapy.

2012/05/N/NZ5/02616

Keywords

Descriptors

  • NZ5_7: Leczenie chorób człowieka
  • NZ5_9: Inne zagadnienia pokrewne

Panel

NZ5 – Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)

Host institution

Warszawski Uniwersytet Medyczny, Wydział Nauki o Zdrowiu

Voivodeship: mazowieckie

Other projects carried out by the institution »

Principal investigator (from the host institution)

dr Piotr Marek Mrówka

Number of co-investigators in the project: 2

Call

PRELUDIUM 3 – announced on 2012-03-15

Amount awarded
98 020 PLN
Project start date
2013-03-12
Project end date
2015-03-11
Project duration
24 months (the same as in the proposal)
Project status
Project settled

Information in the final report

Publication in academic press/journals (1)

  1. PPARγ ligands increase antileukemic activity of second- and third-generation tyrosine kinase inhibitors in chronic myeloid leukemia cells.

    Authors:
    E Glodkowska-Mrowka, A Manda-Handzlik, A Stelmaszczyk-Emmel, I Seferynska,3 T Stoklosa,J Przybylski, P Mrowka
    Academic press:
    Blood Cancer Journal (year: 2016, volume: 6, pages: e377), Publisher: Nature Publishing Group
    Status:
    Published
    DOI:
    10.1038/bcj.2015.109 – link to the publication

« New search

Graphic design and implementation: Jakub Piotrowski